The Latest
-
Markets rally; Merck & Novavax move higher on vaccine hopes
-
Airlines crumble around the globe amid coronavirus pandemic
-
Novavax begins phase one of coronavirus vaccine trial after $388M Gates-backed group funding
-
Merck to buy Austrian vaccine maker as it jumps into COVID-19 race